Dermata Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Dermata Therapeutics, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2022.
  • Dermata Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $235K, a 64.7% increase year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $235K +$92.3K +64.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q3 2021 $143K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q1 2021 $1.34M $0 0% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-21
Q1 2021 $1.34M $0 0% Mar 1, 2021 Mar 24, 2021 10-Q 2022-11-10
Q1 2020 $1.34M Jan 1, 2020 Mar 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.